Home » Stocks » Chiasma

Chiasma, Inc. (CHMA)

Stock Price: $3.83 USD -0.05 (-1.29%)
Updated Oct 26, 2020 4:00 PM EDT - Market closed
After-hours: $3.92 +0.09 (2.35%) Oct 26, 7:43 PM

Stock Price Chart

Key Info

Market Cap 221.38M
Revenue (ttm) n/a
Net Income (ttm) -56.24M
Shares Out 57.80M
EPS (ttm) -1.36
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Oct 26, 2020
Last Price $3.83
Previous Close $3.88
Change ($) -0.05
Change (%) -1.29%
Day's Open 3.88
Day's Range 3.69 - 3.92
Day's Volume 451,224
52-Week Range 2.88 - 7.75

More Stats

Market Cap 221.38M
Enterprise Value 134.30M
Earnings Date (est) Nov 5, 2020
Ex-Dividend Date n/a
Shares Outstanding 57.80M
Float 48.25M
EPS (basic) -1.35
EPS (diluted) -1.36
FCF / Share -1.15
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 1.82M
Short Ratio 3.57
Short % of Float 3.76%
Beta 1.62
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio n/a
PB Ratio 4.33
Revenue n/a
Operating Income -56.54M
Net Income -56.24M
Free Cash Flow -48.51M
Net Cash 87.09M
Net Cash / Share 1.51
Gross Margin n/a
Operating Margin n/a
Profit Margin n/a
FCF Margin n/a
ROA -45.71%
ROE -109.10%
ROIC -126.50%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (5)

Buy 5
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: Buy

Price Target

$13.60*
(255.09% upside)
Low
8.00
Current: $3.83
High
19.00
Target: 13.60
*Average 12-month price target from 5 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Year2019201820172016201520142013
Revenue-----13.1773.13
Revenue Growth------82%-
Gross Profit-----13.1773.13
Operating Income-37.58-32.34-28.13-61.31-35.45-1.8338.61
Net Income-36.32-31.26-26.83-61.11-35.91-2.0136.18
Shares Outstanding34.2024.4024.3724.3211.150.040.04
Earnings Per Share-1.06-1.28-1.10-2.51-3.25-66.21-125.29
Operating Cash Flow-35.01-24.09-24.42-51.96-33.30-6.4046.19
Capital Expenditures-0.31-0.01-0.02-2.83-0.260.08-0.01
Free Cash Flow-35.32-24.10-24.45-54.79-33.56-6.3246.18
Cash & Equivalents92.3841.6666.9492.9814940.1612.85
Net Cash / Debt92.3841.6666.9492.9814940.1612.85
Assets98.8363.2669.8896.7615341.4014.66
Liabilities13.0629.137.4111.0310.298.9314.56
Book Value85.7734.1262.4785.73143-72.02-70.64
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Chiasma, Inc.
Country United States
Employees 68
CEO Raj Kannan

Stock Information

Ticker Symbol CHMA
Stock Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Unique Identifier NASDAQ: CHMA
IPO Date July 16, 2015

Description

Chiasma, a clinical late-stage biopharmaceutical company, focuses on developing oral medications using transient permeability enhancer technology platform for the treatment of rare and serious chronic disease worldwide. The company develops oral octreotide capsules for adult patients under the MYCAPSSA name, which is in Phase III clinical trials for the treatment of acromegaly, a condition that results in the body's production of excess growth hormone. Chiasma, Inc. was founded in 2001 and is headquartered in Needham, Massachusetts.